May 15 – 17, 2026
BIOHUB VLC
Europe/Zurich timezone

Session

Deployment of Nuclear Medicine in LMICs: Pitfalls & Opportunities

May 17, 2026, 9:30 AM
BIOHUB VLC

BIOHUB VLC

C. de la Travesía, Poblados Marítimos, 46024 Valencia

Conveners

Deployment of Nuclear Medicine in LMICs: Pitfalls & Opportunities: Session 9

  • Willy Vangu

Deployment of Nuclear Medicine in LMICs: Pitfalls & Opportunities: Session 10

  • Salah Bouyoucef

Presentation materials

There are no materials yet.

  1. francesco Giammarile
    5/17/26, 9:30 AM
  2. Dr Solomzi Makohliso (Ecole Polytechnique Fédérale de Lausanne)
    5/17/26, 9:50 AM

    Background: Nuclear medical imaging is vital for modern diagnostics, yet access remains profoundly unequal between high-income countries (HICs) and low- and middle-income countries (LMICs). Historically, LMICs have relied on importing or donated equipment designed for HICs. Unfortunately, the WHO estimates that only 10% to 30% of donated medical equipment becomes operational at its...

    Go to contribution page
  3. Salah Eddine Bouyoucef (Emeritus Professor Nuclear Medicine Faculty of Medicine/University Hospital Bab El Oued Algiers Algeria)
    5/17/26, 10:10 AM

    Over the past three decades, several key factors have driven the growth of nuclear medicine in Africa:
    • Capacity building: The development of national policies and strategies by Member States in collaboration with the International Atomic Energy Agency.
    • Expansion of clinical services: Growth in key areas such as oncology, nuclear cardiology, pediatrics, radionuclide therapy, and PET...

    Go to contribution page
  4. Prof. Annick Kouamé-Koutouan (Abidjan Institute of Nuclear Medicine (IMENA)), Dr Nathalie KOUASSI-ABOUKOUA (Abidjan Institute of Nuclear Medicine (IMENA))
    5/17/26, 11:00 AM

    Introduction :
    The Abidjan Nuclear Medicine Institute (IMENA) serves as the sole specialized facility for nuclear medicine in Côte d’Ivoire. Operational since October 2023, IMENA represents a major sovereign investment by the Ivorian government to integrate molecular imaging into the national healthcare system.
    This study provides an assessment of the initial operational phase, an analysis...

    Go to contribution page
  5. Dr Subhash Kheruka (Sultan Qaboos Comprehensive Cancer Care and Research Centre, UMC, Muscat, Oman)
    5/17/26, 11:20 AM

    Nuclear medicine plays an increasingly important role in modern healthcare, especially in the diagnosis and management of cancer, cardiovascular disease, and other serious conditions. Even so, access to these services remains limited in many low- and middle-income countries (LMICs). In many cases, the issue is not simply a lack of equipment. The bigger challenge lies in building systems that...

    Go to contribution page
  6. Willy Vangu (CM Johannesburg Academic Hospital, University of the Witwatersrand)
    5/17/26, 11:40 AM

    South Africa has one of the most developed nuclear medicine systems in a low and middle income country (LMIC) setting and offers valuable insights into the challenges and opportunities of sustaining nuclear medicine in resource constrained environments. The country faces a dual burden of infectious diseases and rising non communicable diseases, including cancer and cardiovascular disorders,...

    Go to contribution page
  7. Francesco Giammarile

    Expanding access to nuclear medicine and molecular imaging in low- and middle-income countries (LMICs) remains a major global health challenge. Despite the growing importance of these technologies in oncology, cardiology, and other non-communicable diseases, significant disparities persist in infrastructure availability, trained workforce, and sustainable supply chains for...

    Go to contribution page
Building timetable...